Alpha Tau Medical Ltd.
General ticker "DRTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $358.6M (TTM average)
Alpha Tau Medical Ltd. follows the US Stock Market performance with the rate: 54.8%.
Estimated limits based on current volatility of 8.6%: low 9.14$, high 10.51$
Factors to consider:
- Total employees count: 88 as of 2021
- Current price 45.8% above estimated high
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.13$, 7.26$]
- 2026-12-31 to 2027-12-31 estimated range: [2.45$, 5.90$]
Short-term DRTS quotes
Long-term DRTS plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $36.04MM | $42.29MM |
| Operating Income | $-36.04MM | $-42.29MM |
| Non-Operating Income | $4.30MM | $-0.22MM |
| Interest Expense | $0.34MM | $0.42MM |
| R&D Expense | $27.02MM | $30.83MM |
| Income(Loss) | $-31.74MM | $-42.51MM |
| Taxes | $0.01MM | $0.12MM |
| Net Income(Loss)* | $-31.75MM | $-42.63MM |
| Stockholders Equity | $62.67MM | $77.10MM |
| Assets | $86.20MM | $106.58MM |
| Operating Cash Flow | $-19.78MM | $-26.68MM |
| Capital expenditure | $2.24MM | $6.08MM |
| Investing Cash Flow | $20.77MM | $-20.59MM |
| Financing Cash Flow | $0.03MM | $45.77MM |
| Earnings Per Share** | $-0.45 | $-0.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.